REVITOPE ONCOLOGY
Live / Registered — Registered (as of 04 Jan 2022)
What this means for you
Registered since 04 Jan 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90430409
- Registration number
- 6605913
- Mark type
- Stylized text
- Filed
- 30 Dec 2020
- Published for opposition
- 19 Oct 2021
- Registered
- 04 Jan 2022
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations for the treatment of cancer; development of platform technology, namely, immunotherapy platforms for manufacturing cancer therapeutics; scientific research services, namely, antibody engineering for analytical and clinical purposes
Owner
- Revitope Oncology, Inc., Cambridge, MA, US
- Revitope Oncology, Inc., Cambridge, MA, US
- Revitope Oncology, Inc., Cambridge, MA, US
Prosecution history
- 04 Jan 2022 — REGISTERED-PRINCIPAL REGISTER
- 19 Oct 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Oct 2021 — PUBLISHED FOR OPPOSITION
- 29 Sept 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Sept 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Sept 2021 — EXAMINER'S AMENDMENT ENTERED
- 14 Sept 2021 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 14 Sept 2021 — EXAMINERS AMENDMENT E-MAILED
- 14 Sept 2021 — EXAMINERS AMENDMENT -WRITTEN
- 11 Jul 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Jul 2021 — NON-FINAL ACTION E-MAILED
- 11 Jul 2021 — NON-FINAL ACTION WRITTEN
- 20 Jun 2021 — ASSIGNED TO EXAMINER
- 24 Mar 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 02 Jan 2021 — NEW APPLICATION ENTERED